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When the potent immunosuppr,essive sesquiterpene ovalicin is added to Iymphocyte cultures one .first 
observes a preferential inhibition of uridine incorporation into rRNA. The uptake of the nucleoside, its con-
version into the triphosphate or the polymerizing activity itself are not affected. A longer period of incubation 
witb the drug results in a marked decrease in the number of ribosomes, with a concomitant reduction of the rate 
of leucine incorporation into all cellular proteins. After extended periods of time, the incorporation of thymidine 
into DNA in stimulated lymphocytes as weIl as in S 49.1 lymphoma cells is inhibited by 1 nM ovalicin or less, 
although part of the incorporation seems to be resistant to the drug even at much higher concentrations. A similar 
effect is observed with 3T6 mouse fibroblasts or HeLa cells. Here, however, a much longer incubation with the 
drug is required. This observation explains the selective effect of ovalicin on Iymphocytes observed in vivo .. 
The sesquiterpene ovalicin [1- 3] has been shown to be 
oue of the most potent immunosuppressive drugs in cell cul-
ture. A drug concentration of 1 - 0.01 nmol/l is sufficient to 
inhibit significantly the antigen-induced formation of anti-
bodies as weIl as the mixed Iymphocyte reaction and the pro-
liferation of murine or human lymphocytes following stimu-
lation with various mitogens [4]. The addition of ovalicin to 
cell cultures several hours after the mitogen does not result 
in areduction of the inhibitory effect. Therefore the very 
early events in the ceIl cycle of Iymphocytes cannot be the 
target of the drug [4]. On the other hand, ovalicin does not 
reduce the incorporation of radioactive thymidine into DNA 
when added during the S-phase or shortly before it Conce-
quently DNA synthesis itself and reactions c10sely connected 
with it in time are also excluded as the targets of this inhibi-
tor [4]. These and other observations [4] suggest that ovalicin 
primarily affects some reactions which occur in lymphocytes 
after the early phase of induction and prior to the S-phase. 
Oue of the crucial reactions in the sequence of events required 
for the proliferation of lymphocytes is the biosynthesis of 
rRNA [5] which is necessary for the formation of ribosomes. 
The number of active ribosmes present in resting lympho-
cytes is too low for cell proliferation. Mitogenic stimulation 
causes a 3-4-fold increase followed by attainment of a high 
levelof pro tein synthesis which in turn is aprerequisite far 
DNA synthesis [6 -9]. It therefore appeared of interest to 
investigate the effect of ovalicin on the synthesis of rRNA 
and its relationship to the synthesis of proteins and DNA. 
MATERIALS AND METHODS 
Cell Culture 
Spleen cells from B6D2F1 mice (Bomhoitgard, Ry, Den-
mark) were cultured in Eagle's minimal. medium without 
l-leucine(Autopow MEM, Flow Laboratories, Bonn) supple-
mented with52 mg L-Ieucine(l and 2.5% fetalcaIf serum, 
previously heat-inactivated, in plastic fIasks at acellconcen-
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tration of 2x106 /ml. After a 12-14-h preincubation the 
experiments were started by addition of 1 !lg concanavalin A 
(Pharmacia, Freiburg) per ml, lO!lM 2-mercaptoethanoland, 
if indicated, ovalicin (Sandoz SA, Basel, Switzerland). All 
added compounds were dissolved in Hank's solution. 
S 49.1 lymphoma cells (obtained from U. Gehring, Hei-
deI berg), 3T6 murine fibroblasts or HeLa cells (both obtained 
from E.-L Winnacker, München) were cultured in Dul-
becco's medium without non-essential amino acids in the 
presence of 10% fetal calf serum, 0.3 g penicillin/I, 0.1 g 
streptomycin/I. 
Incorpo/"ation of r H]Uridine or r HjThymidine 
into Acid-Insoluble Material of the Cells 
At the time indicated O.9-mI aliquots (in duplicate) of tbe 
suspended cells were transferred into small plastic tubes. 
0.11 radioactive nucleoside solution containing 1!lCi [5_3 H]_ 
uridine (0.2 CijmmoI, Schwarz-Mann, Heidelberg) or 1 !lCi 
[methyPH]thymidine (0.5 Ci/mmol, New England Nuc1ear, 
Dreieichenhain) dissolved in culture medium was added and 
the incubation continued as indicated. Subsequently the cells 
were collected on glass fibre filters (Whatman GF /C)and 
washed with 5 % trichloroacetic acid in a similar way as de-
scribed previously [10]. The radioactivity remaining on the 
filter was determined. 
Incorpo/"ation of rHjLeucine 
infO Acid-Insoluble Material of the Cells 
At the time indicated 0.9-mI aliquots (in duplicate) of 
the suspended cells were transferred into small plastic tubes. 
The medium was replaced with leucine-freemediumand 5!lCi 
[4,5-3H]leucine (Amersham-Buchler, Braunschweig) was 
added (resulting specific radioactivity 0.3Ci/mmol) and the 
ceIls iocubated for 2 h. Then the cells were separated [rom 
the radioactive medium bycentrifugation,washed in 2m} 
cold phosph.ate-bufferedsaline containing O.1%NaN3and 
subsequeotlylysed ioO.2 mI1 M NaüHat 56°C forl0min. 
The protein was precipitated with 2 ml 10% trich!oroac,etic 
acid contaioingtU3 mg L-leucineJml andcoUected after 1.h 
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on toglass-fibrefilters{Whatman HF jC). Afterfurther wash-
ingwithtrichloroacetic acid and methanol the radioactivity 
remain:ing on the filter was determined. 
Pulse Labellingol RNAin Stimulated Lymphocytes 
Two cultures with 3 x 107 Iymphocytes were stimulated as 
described, one of the cultures in the presence of 0.2 jlM ovaIi-
cin; 12 h later 3.45 IlM [3H]uridine (2 Ilei/ml) was added to 
theculture without the drug, whereas the same concentration 
of [2_14CJ uridine (Schwarz-Mann, Heidelberg, 0.2 IlCi/ml) 
was added to the culture containing the drug. Both cultures 
were incubated for 1 h. The concentration of uridine was sub-
sequently increased to 1 mM with unlabelled nucleoside 
for 30 min in· the pulse-chase experiment. Simultaneously 
5 .!lg ofactinomycin Dlml was added. Then both cultures 
were combined andproteindenatured with phenol in the 
presence of dodecylsulfate [11]. RNA, precipitated with 
ethanol, was dissolved in buffer[12] and separated electro-
phoretically inpolyacrylamide gels containing 0.5 ~~ agarose 
[12). To determine of the radioactivity the gels were cut 
into 1-mm slices which were incubated overnight by shaking 
in Soluene 350 (packard, Frankfurt) at room temperature 
and, subsequently, for 1 - 2 h at 50 oe. After addition of the 
scintillation cocktail the radioactivity of 14C and 3E was 
measured separately; the measured values were corrected for 
spillover. 
Cell-Free System 101' the Incorporation 01 rH J UM P 
into RNA . 
Nudei were prepared by treatment of 108 Iymphocytes, 
which had been stimulated for 36 h (control without con-
canavalin A) with or without 0.2 !lM ovalicin, with 0.25 M 
sucrose containing 5 mM CaCh, 25 mM 4-(2-hydroxy-
ethyl)-l-piperazineethanesulfonic acid (Serva, Heidelberg) 
pH 8.0 and 0.5 ~~ Brij 58 (Serva., Heidelberg) as described [13) 
and used directly for the assay. The incorporation of [3H]!_ 
UMP from [3H)UTP into RNA of the isolated nuclei was 
measured essentially as described [14] with 2 x 106 nuclei per 
assay in the presence or absence of 20 11M ovalicin. 
Electrophoretic Analysis 01 14C-Labelled Praleins 
The cells which had been ineubated with 1 !lCi/ml of 
[14C)leueine (0.11 Ci/mmol, Schwarz-Mann, Heidelberg) were 
separated from the medium by centrifugation, washed with 
10ml 0.85 % NaCl and frozen... After thawing the cells 
were dissolved in 40 !ll 50 mM Tris/HCI pH 6.8 containing 
2.5/~ sodium dodecylsulfate, 8 % glycerol and 5 % 2~mercapto­
ethanol; 20-1.11 aliquots were applied to slab gels [15) with a 
linear 5 -15/~ acryl amide gradient. Electrophoresis was 
carried out for 16 h at 60 V. Autoradiography was performed 
with DuPol1t Cronex 2 X -ray screen film NIF 200 for 7 days. 
Determination. 01 Ribosomes in Stimulated Lymphocytes 
Freshly iso la ted Iymphocytes (1.1 x 108 ) were stimulated 
withconcanavalin A.Oneculturecontained· in addition 
O.2!lM ovalicin. After 23 h 10!lM 2-mercaptoethanol was 
added and theincubationcontinued for 17 h. Then 0.9~ml 
aliquots (induplicate) were removed to determine the rateof 
incorporationof [3H]leucine (5 IlCi/mI; 13 Ci/mol) into 
add-insolublemateriaI with a 4~hpulse ina similar way to 
thatdescrihed .previously [16]. Theremainingcells were used 
to isolate the ribosomes as described [17]. The amount of 
ribosomes was characterizedhy the content of RNA as 
determined by the absorbance at 260 nm [18]. 
RESULTS 
lncorporation 01 Uridine 
Pr,eviously we have shown that, in activated lymphocytes, 
the incorporation of radioactive uridine into acid-insoluble 
material 1S partly inhibj!ed by ovalicin [4). The effect of the 
drug was studied in a cell-free system to prove that this 
inhibition refiects a decrease in RNA synthesis and not a 
reduction of the uptake of uridine, an inhibition of üs con-
version into ribonucleoside triphosphate or a change of the 
pool size of the precursor. The incorporation of [3H]UTP 
into nudei from lymphocytes activated by concanavalin A 
either in the presence or absence of ovalicin was determined 
(Table 1). As can be seen, nudei obtained from cells treated 
with ovalicin show a markedly reduced incorporation :Jf 
nudeotide, indicating that the drug inhibits the incorporating 
system or its formation and not the uptake by or metabolism 
of the precursor in intact cells. When the drug was added to 
nudei obtained from cells stimulated in the absence of ovali-
eine no reduction of the incorporation was found (Table 1). 
This indicates that ovalicin does not directly interfere with 
the catalytic process of the polymerizing system. This con-
dusion, however, rests on the assumption that the active 
agent is the drugitself and not a metabolised form of it. 
The observation that in cell culture the extent of the 
inhibition is independent of the length of the uridine pulse 
(between 5 - 60 min, data not shown) also supports the notion 
that uptake and metabolism of the precursor are insensitive 
to the action of ovalicin. In agreement wirh this condusion 
the apparent Michaelis constant for uridine during the incor-
poration into RNA (Km = 2.95 !lM) is not infiuenced by 
ovalicin. It therefore seems likely that the reduced labeJling 
ofRNA in the presence of ovalicin is either due to an inhibition 
of its biosynthesis or a stimulation of its degradation. 
For a doser analysis of the effect of the drug on the 
metabolism of rRNA, the following experiment was carried 
out Concanavalin A was added to a culture of resting murine 
spleen lymphocytes together with ovalicin, which was omitted 
in the control; 12 h later [J4C)ufidine was added to the cul-
ture containing the drug, whereas [3H]uridine was given to 
the controL The labelling period of 1 h was followed by a 
0.5 h chase with a 300-fold excess of unlabelled uridine. 
Actinomycin D was simultaneously added to prevent the 
incorporation of labelIed nudeotides released during the 
degradation of radioactive RNA .[19]. Both cultures were 
subsequently combined, RNA was extracted and analysed by 
electrophoresis in a polyacrylamide gel. Fouf radioactive 
peaks are observed corresponding to 28-S, 18-S., 5-S and 4-S 
RNAs as calculated from the mobility of marker RNAs 
(Fig. 1 A). Almost no radioactive RNA larger than 28S was 
observed in agreement witb the fact that large hnRNA is 
rather unstable with a half life of only 8 min [20]. The deter-
mination of the ratio eH]uridine/p4C]uridine in the gel 
clearly shows that ovalicin inhibits the incorporation of tbe 
labelled precursorinto the three species of crRNA to a much 
grater extent than into 4-S RNA (Fig.l B) .. The inhibition i5 
notcomplete and amounts to 35 - 44 % (Table 2). This is not 
due to an insufficient time of incubation with the drug (in 
these experiments 12 h)sincea.constantlevelofinbibition is 
reached in a much shorter time as will be shownbelow 
Tablel .. 1Ilcorporatiollof !"HjUMP illto nudei from lymphocytes stimu-
lated in the presence or absence of ovalicin without or with further addition 
ofthe drug 
Spleen lymphocytes were cullured for 36 h in the absence or presence of 
0.2 ~ ovalicin. 8ubsequently nuclei wereprepared and the incorpora-
!ion of [3HjUMP from [3HlUTP at 25 oe for 60 min intoacid-insoluble 
material was determined. The valueofa control with zero-time incuba-
lion (1268 counts x min~l) has been substracted. The data are mean 
values of determinations performed in duplicate which differed by less 
than 6% 
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Table 2. Inhibition by ovalicillofthe labelling of rRNA withradioactive 
ul'idine in stimulated lymphocytes 
The inhibition wascal.culated from the data shown in Fig. I as follows. 
If the incorporation of r3HjUMP in the presence orabsence of ovalicin 
is designated as a and a', respectively, andthat of['4C]UMP as band b', 
respectively, the inhibition I (in %) by the drug of the incorporation of 
the uridine nucleotide into a particular fraction r ofRNA can becalcu-
lated from the measured ratio (a'lb), (see Fig.! H) by theequation 
1= 100 [1 - F/(a'lb),], where Fis the ratio a'lh' = alh, given by the 
specific radioactivity of the labelIed nucleotides incorporated and the 
mixing ratio of the two incubation sampies (Fig.!), which is independent 
ofthe particular RNA studied. The ratio alb was determined priorto the 
electrophoretic fractionation as 5.75 ± 0.38 from aja' = 0.664 ± 0.020 
and a'jb = 8.67 ± 0.30 (mean values of two deterrninations) according 
to a/b = (aja')(a'jb) 
rRNA species ['HjUMP/I'4QUMP Inhibition 
incorporated 
% 
28 S 8.8 ± 0.3 35 ± 6 
18 S 10.3 ± 0.3 44 ± 6 
58 9.0 ± 0.3 36 ± 6 
(Fig.3). The incomplete inhibition could be due to the use 
of a spleen cell culture which contains, among other cells, 
several classes and subclasses of Iymphocytes with possibly 
different sensitivities to the drug. This question will be investi-
gated in future work using cdl lines. The labelling of the 
individual rRNAs appears to be inhibited by ovalicin to a 
somewhat different extent (Table 2).. Similar observations 
have been made in other experiments without ovalicin and 
explained in different ways [21,22]. 
In order to study the effect of ovalicin on the labelling 
of the unstable hnRNA the experiment was repeated; how-
ever, this time the chase with unlabelled uridine was omitted. 
In suhsequentelectrophoretic analysis polyacrylamide gels 
with a: higher degree of cross-linking were used for better 
separation of large hnRNA from rRNA. Again, the labelling 
of rRNA is clearly inhibited by the drug. In contrast the 
labelling of the high-molecular-weight RNA remaining at the 
start is much less reduced (Fig.2). Assuming that the pre-
cursor for the synthesis of the various species of RNA is 
derived from the same pool, these results suggest a specific 
effect of ovalicin on the metabolism of rRNA. In agreement 
with the observation that the metabolism of rRNA is insig-
nificantin resting Iymphocytes [20j, the inhibition of the 
labelling of RNA in these cells is very smaJl(7.5 ± 6.2 %) 
even after a 19-h incubation with ovalicin (data not shown). 
The DNA-dependent RNA polymerase I responsiblefor 
the biosynthesis of the rRNA precursor can be ruled out as 
the target of ovalicin since no effect of the drug on RNA 
polymerase I purified from murine MOPC cells is detect-
able in vitra (W. A. Zimmermann, unpublished observations). 
In the experiments described above, the inhibitory eirect is 
observed after exposing the ceils to the drug for 12 h. If the 
metabolism·of rRNA is rathercloselyconnected in time with 
the molecular target of the drug, the inhibition should be 
observable after a shorter time of exposure. To ans wer ihis 
question spleen cells were stimulated with mitogen.Ovalicin 
was then addedatdifferent limes; 12 h after addition of 
the mitogen thelabelling of RNAwasmeasured with a l-h 
pulse of eH]uridine. In agreement withthepreviousexperi-
mentsan inhibitionof 35 % wasobservedaftera long incuba-
tion with the drug(Fig. 3). Buteven when ovalicin was added 
only 1 h before the pulse a distinctinhibition (50%of the 
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Eig- 3. Kinelics ofthe inhibitoryactioll of ovalicin Oll theillcorporatir)1lof 
rH Jur.idineinto RN Aaf stlmulated lymphocytes. Ovalicin (Ov, final con-
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Table 3. Effect of ovalicinon thecontent ofribosomesandon lherateaj 
incorporation of ['Hjleucine inta pro/ein in stimulated lymphacytes 
The incubation of lymphocytes, pulse-Iabelling witb [3H]leucine, isola-
tion of ribosomes and determination of rRNA content was performeiI 
as described in Materials and Metbods., Tbe data are mean values of 
determinations performed in duplicate 
Ovalicin 
IlM 
0.2 
o 
Ribosomes 
Ilg rRNA,72 x 10" cells 
168 ± 8 
320 ± 15 
Incorporation 
of ['H]leucine 
during 4 h 
into 2.07 x 107 cells 
counts x min -1 
11968 ± 553 
22001 ± 189 
maximum) was found. This effect of the drug is the earliesl 
one detectable so far. Consequently we have to conelude 
that the metabolism of rRNA must be rather closely cOllllected 
with the molecular target of ovalicin. 
Incorporation of Leucine 
Any reduction of the synthesis of rRNA should lead to a 
decrease in the formation of new ribosomes. lndeed, when 
the conten! of ribosomes in lymphocytes is determined, we 
find that cells stimulated in the presence of ovalicin contain 
half as many ribosomes as the control cells without the drug 
(Table 3). Areduction in the number of ribosomes should 
lead to a decrease in the rate of protein synthesis, which cau 
be measured by the incorporation of radioactive leucine into 
proteins since exogenous leucine readily equilibrates with 
intracellular leucine. Uptake and the size of the pool of ffee 
amino acid do not change significantly after stimulation ofthe 
lymphocytes [7,23,24]. When the incorporation of [3H]_ 
leucine was measured in parallel with the conten! of ribo-
somes, it was found that the incorporation in the presence of 
ovalicin was only 50 % of that of the untreated control 
(Table 3). 
Ir the reduction of pro tein synthesis by ovalicin is caused 
by the decrease in the number of ribosomes, the synthesis of 
an proteins should be uniformly affected. To test this notion 
murine spleen lymphocytes were stimulated with mitogen in 
thepresence or absence of ovalicin. At various times after 
stimulation, proteins were labelIed by a 4-h pulse with [14C]_ 
leucine. Subsequently thecens were dissolved in buffer con-
taining dodecylsulfate and the proteins fmctionated by gel 
electrophoresis. The incorporation of radioactive leucine 
into the numerous zones of protein was monitored by auto-
radiography (FigA). The incorporation of radioactivity in-
creased with the time of exposure to the mitogen. This is 
particularly evident for the most rapidly migrating zones 
which include the proteins required for DNA replication 
suchas histones [25]. After a longer period ofincubation 
less radioactivity was incorporated in the presenceof the 
drug. Nevertheless the pattern and the ratio of the intensities 
of the radioactive zones within a slot was the same in thc 
presence and absence of the drug. A similar result was found 
when. the sensitive doubIe-labelling method was used (data 
not shown). These results suggest that ovalicin inhibits uni-
formly the biosynthesis of the various classesof proteins. 
Finally it is of interest to determine the kinetics ofinhibi-
tion of leucin.e incorporation with thatofuridine incorpo-
ration .. Murine spleen cells were stimulated withmitogel1 
in the presenceofovalicin.Controls withoutthe druga.nd{or) 
Time [14C]leucine added(h) 
Fig.4. Effect of ovalicin 0/1 the i/1corporatio/1 of ['4Cjleucine info different 
/rac/ions of pro/ein in stimulated lymphocytes. The radioactive amino 
acid was given to the cells at different limes (as indicated) after addition 
of 0.2 11M ovalicin (ov) and concanavalin A for 4 h. The incorporation 
was visualized by autoradiography of the dried gel after electrophoresis. 
Ta increase the specific radioactivity of the labelIed amino acid the cells 
were washed with leucine-free medium prior to !he addition of 1 IICi 
[14C]leucine (resulting specific radioactivity 0.11 Cijmmol) 
without mitogen were run in parallel. At different times after 
the start, the incorporation of [3H]leucine into acid-insoluble 
material was measured during a 2-h pulse (Fig.5). Ovalicin 
reduces the incorporation by 15 % after an 11-h incubation. 
A really significant inhibition was only observed much later. 
When comparing these results with the kineücs of the inhibi-
tion of uridine incorporation (Fig.3) we have to conclude 
that the inhibition of Ieucine incorporation takes distinctly 
longer. 
1l1corporation 0/ Thymidine 
It has been reported that the incorporation of radioactive 
thymidine into DNA is also inhibited by ovalicin, although 
a considerable time of incubation is required toachieve a 
substantial effect [4]. Thisinhibition is not caused by a 
significant change in the uptake, the metabolism or the size 
of the pool of the precursor since it is alsoobserved in acell-
free system of nuc1ei wheredTTP serves as precursor[4}. 
This notion is supported by theobservation that theextent 
of inhibition caused by the drug is independent ofthe concen-
trationof thymidine used (datanot shown). Thereforewe 
conclude that the inhibitionof thymidine incorporation by 
ovalicin refiects an dfecton thesynthesisof DNA. 
. Thedose-responsecurve ofthiseffect (Fig.6) shows two 
luteresting(eatures: (a) amaxllnum ·of inhibition is reached 
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Fig.6. Effect of different concenlrations ofovalicin 0/1 the i/1corpora/ion of 
[3H}thyrnidine info DNA ofslimulated lymphocyles. At 30 h after addition 
of the mitogen and ovalicin, 0.9-mlaliquots (in duplicate) were trans-
ferred to small plastic tubes to determine the incorporation of [3H]_ 
thymidine during a l-hpulse into DNA (100% = 20896 counts xmin-') 
with less than 1 ng ovalicinjml; (b) 35 % of the incorporation 
is resistant to the drng even wben its concentration is in-
creased 50-fold. This suggests that the resistant incorporation 
may be a consequence of using an unfractionated spleen cell 
culture containing several classes of Iymphocytes with pos-
siblydifferent sensitivities to the drug .. It was therefore of 
interest to investigate the effect of ovalicin onmonoclonal 
lymphoidcells such as S 49.1 lymphoma cells [26] (Fig. 7 A). 
In this experiment S49.1 ceUs were incubated for various 
periods of time (starting from alm ost onecellcycle up to three 
cellcycles) :with different conce;ntrations of ovalicin. Subse-
quendy the incorporation of ffIlthymidineinto DNA was 
determined during a 1"h pulse. It isevidentthat S 49.1 ceUs 
were inhibited at thesame lowconcentrationof ovalicin .ag 
o 
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Fig .. 7. Effect of different concentrations of ovalicin and of the time of incu-
bation on the incorporation of ['H]thymidine into DNA and on the cell 
number of a S 49.1 lymphoma cell culture. (A) To exponentially growing 
cells (0.15-0.3 x 106 cellsjml) ovalicin (as indicaled on the abscissa) was 
added. After the time indicated in the figure. 0.9-ml aliquots (in duplicate) 
were transferred 10 small plastic tubes to determine the incorporation of 
fH)thymidine into DNA during a l-h pulse: 100 % = 11 084 (f,,), 23213 
(.1..),39115 (0), 56431 (e) or 70820countsxmin- 1 (0). (B) Exponen-
tiallygrowing cells were diluted with fresh medium containing 0.2 iJ'M 
ovalicin to 0.15 x 106 cells/ml. At the time ind~d on the ahscissa the 
number of cells and the number of vital cells (as' measured by the 
exclusion of trypan blue) was determined microscopically. Total cell 
number: (0) without ovalicin; (_) with ovalicin; vital cells: (f,,) without 
ovalicin;. (1..) with ovalicin 
spleenlymphocytes. Again, part of the incorporation of thymi-
dine into DNA is resistant to the drug irrespective of its con-
centration. However, the extent of resistance is strongly depen-
den! on the time of incubation of the ceUs with ovaliciu. A 
rather short incubation (less than one cell cycle) leads to low 
inhibition. Only after a much longer incubation was the incor-
poration substantially reduced. If one determines the number 
of ceUs in such an experiment, it becomes obvious that 
ovalicin has almost no effect for the first 24 h (Fig. 7 B). U pon 
further incubation the total number of cells remains con-
stant but cells start to die and become permeable for trypan 
blue. Obviously the inhibition of proliferation by ovalicin is 
a late effect in agreement withthe findings in stimulated 
spleenlymphocytes [4]. 
Indeed aUshort-term effects of ovalicin seem to be com-
pletely reversible up to 12h of incubation as is suggested 
fromthefollowingexperiment. Ovaiicin was added to expo-
nentiallygrowing S 49.1cells and incubation was continued 
for 12 h. Then theconcentration of the drug was lowered to 
0,02 nM by washing the,cells with fresh medium where upon 
tj:reincubation was continued. Theincorporation of thymidine 
into DNA was measured by f-hpulses at various times 
(F}g.8). The niteofincorporation remained the same as in the 
control without the drug. When the drug was not removed 
theincorporatioTl.was stfonglyinhibiteduponfurther incu-
bation. 
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Fig. 8. Reversibility of the inhibitory action of ovalicin on S 49.1 lymphoma 
cells. 20 nM ovalicin was added 10 exponentially growing cells (0.15 
-0.3 x 106 cells/ml).; (0) controls without drug. 12 h bter the cells were 
removed from the medium by centrifugation, washed and resuspended 
in fresh medium without thedrug (f,,) (resulting conc,entration of ovalicin 
in the medium 20 pM) or in medium with 20 nM drug ce). 1 h prior to 
the time indicated., 0.9-ml aliquots (in duplicate) were transferred to 
small plastic tubes to determine the incorporation of [3H]thymidir.e 
into DNA during a l-h pulse 
Effects on Non-lymphoid Cells 
Fram the comparison of the influence of ovalicin on the 
number of mitoses in different cells [2], it is known that non-
lymphoid cells appear to be much less susceptible to the 
action of this drug. Therefore we became interested in 
investigating its action on the incorporation of thymidine 
into cultures of 3T6 mouse fibroblasts and human HeLa cells. 
lt is evident that the inhibition was but small but it increased 
with the time of incubation (Fig. 9 A) and, interestingly, 
became evident at the same low concentration of ovalicin as 
in lymphocytes (Fig. 9 B). The unusually low concentration 
of the drug required for inhibition suggests a similar mode of 
action in alleukaryotic cells tested. However, in all rapidly 
dividing cells the inhibition is detected only after an incuba-
tion of the cells with ovalicin for more than one cell cycle 
(Fig..7 and 9). 
DISCUSSION 
The first detectable effect of ovalicin on stimulated lym-
phocytes is the specific inhibition of the incorporation of 
radioactive uridine into rRNA (Fig. 3). Upon a Ion ger period 
of incubation the number of ribosomes per celland the rate 
of incorporation of radioactive leucine into prateins and of 
labelled thymidine into DNA is also reduced. All these effects 
inc1uding those occurring after a long exposure of the cells 
to the drug are observed with very low concentrations ofthe 
inhibitor. It is important to stress this fact because at higher 
concentrations hydrophobic drugs such as ovalicin canbind 
to many different sites in the cellby rather unspecifichydro-
phobic interactions with the consequence ofiTl.hibiting 
several reactions separately and independently as hasbeen 
proven for the rifamycins [27,28] or novobiocin andnalidixic 
acid [29]. At such low concentrationsof a.drug (100'- 0.1 nM) 
as were used in our experimentsunspecific bindinghasnot 
been reported so far for other drugs. Thereforeit appears 
reasonable toassume a single target forovalicin.Its blockade 
could then leadviaachainof metabolicevents to theinhibi-
tionof many other reactions. Thishypothesis is supported 
by thekinetics ofthevarious inhibitory effects. Exceptfotthe 
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Fig.9. Effect of different concentra/ions of ovalicin on the incorporation 
of {3Hjthymidine into DNA of HeLa cells or 3T6 murine fibroblasts. 
(A) Ovalicin (as indicated) was added at 6 h 10 HeLa cells (0) or at 9 h 
to 3T6 cells (,e) after suspending the cells in 2 ml fresh medium. 48 h 
after addition of the drug, 2 fiCi [3H]thymidine (specific radioactivity 
0.5 Ci/mmol) was aodded and the incubati.on continued for 1 h; 100 % 
incorporation = 1332 counts x min -1 for HeLa cells or 12861 counts 
x min -1 for 3T6 ceUs. (B) Ovalicin was added as in (A). 1 h be fore the 
time indicated on the abscissa 2 fiCi ['H]thymidine was added to C .... ) 
HeLa cell.s (specific radioactivity 6 Ci/mmol) or (e) 3T6 cells (specific 
activity 0.1 Cijmmol) and the incubation continued for 1 h. 100 % values 
in countsxmin- 1 were for HeLa cells: 4552 (1 h), 7624 (13 h), 11208 
(25h), 23404 (37h) and 33910 (49h); for 3T6 cells: 632 (1 h), 1390 (13h), 
2820 (25 h), 5010 (37 h) and 9930 (49 h) 
inhibition of the incorporation of uridine into RNA all other 
effects are observed only after severaI hours of incubation. 
lt is not yet known how ovalicin on the molecular level, speci-
fically reduces the formation of 28-S, 18-S and S-S rRNAs, 
but this will be the subject of further studies. During the 
stimulation of the Iymphocytes the rate of synthesis of rRN A 
increases more than that of hnRNA [5,20]. As a consequence 
the total number of ribosomes in lymphocytes increases 
3-4-fold during the stimulation [6,7] with a concomitant 
increase in the capacity to synthesize proteins. This, however, 
is not the initial mechanism stimulated lymphocytes use to 
increase their rate of protein synthesis. Rather, theprimary 
step is the activation of inactive ribosomes preexisting in 
the cell [30,31]. In agreement with these findings the forma-
tion of blast cells from small lymphocytes, a process which 
requires protein synthesis, is only weakly reduced by ovalicin 
[4]. Por the subsequent process of proliferation the number 
of ribosomes in the cell may be rate-limiting [32].. This is not 
unexpected because DNA synthesis in eulcaryotic cells 
requires a very active. and simultaneous synthesis of proteins, 
particularly of histones wh ich are necessary for the forma-
tion ofchromatin [9].. Thenifore, a reduction of the number 
of newly fonned ribosomes by ovalicin should also diminish 
thecapacity to synthesize DNA as has been reported [4]. 
!he very same reasoning explains why the inhibition of the 
lUcorporationofthymidine into DNAby ovalicin is never 
comp1ete. The ovalicin-resistant DNA synthesis may be 
s~mply the consequence ofprotein synthesis on preexisting 
llbosomes inthe Iymphocyte. 
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Anotherexplanation for tbepartial resistancecould be 
based on the existenceof several populations of ceUs in the 
culture which differ in the content of ribosomes, implyinga 
critical number of ribosomes for the initiationof DNA syn-
thesis. This hypothesis also explains the apparent insensitivity 
of non-Iymphoidcells to ovalicin,at least when thesecells 
are incubated with the drug for only one cell cyde. Only 
resting lymphocytes are particularly deficient in ribosomes 
and have to increase th,e number upon stimulation before the 
S-phase can beentered for the first time [6,7]. Incontrast, 
rapidly proliferating cells such as lymphomacells, HeLa 
ceUs or fibroblasts apparently contain a sufficient number of 
ribosomes to initiate chromatin synthesis. Consequently 
these cens can proliferate even in the presence of inhibitors 
of tRNA synthesis such as small doses of actinomycin D 
for more than one cell cyde before the number of ribosomes 
becomes rate-limiting [32 - 34].. Consequently such cells 
resist the action of ovalicin for longer times than stimulated 
Iymphocytes (Fig.7 and 9). 
These investigations have been supported by the Fonds der Chemi-
schen Industrie aud the Deutsche Forschungsgerneinschaft. Ovalicin was 
kindly provided by Drs H.-P. Sigg and H. Staehelin (Sandoz AG, Basel). 
We are indebted 10 Professor U. Gehring (Institut für Biologische 
Chemie, University of Heidelberg) for providing us with Iymphomacells 
and [or advice on growing them in culture and to Professor E.-L. Winn-
acker and his associates (Institut für Biochemie, University of München) 
for help in the experiments with HeLa and 3T6 cells. 
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